Fluidome Team
Executive Leadership
Mehdi Mohammadi, PhD, PMP
Co-founder, CEO & Metabolomics Technology Developer
Driving end-to-end translation of biomarker discovery into scalable diagnostic products
Dr. Mehdi Mohammadi is the Co-Founder and CEO of Fluidome, where he leads corporate strategy, product development, and commercialization of next-generation diagnostic and analytical platforms. He oversees the full innovation pipeline—from biomarker discovery to scalable, market-ready biosensor technologies.
With over 20 years of experience across engineering, biotechnology, and translational medicine, he has led 30+ multidisciplinary R&D programs and contributed to the development and commercialization of multiple technologies. His expertise spans metabolomics, microfluidics, and electrochemical biosensing.
Dr. Mohammadi brings a strong combination of technical depth and business leadership, driving product–market fit, strategic partnerships, and growth in the life sciences and diagnostics sectors.
Atefeh Rafiei, PhD
Co-Founder, CTO & Proteomics Technology developer
Driving technology strategy and scalable platform development across omics and diagnostics.
Dr. Atefeh Rafiei is Co-Founder and Chief Technology Officer at Fluidome, where she leads the development and integration of the company’s core technology platforms. She oversees the translation of omics-driven insights into scalable, high-performance diagnostic systems.
With a background in chemistry and over a decade of experience in bioanalytical science, she has led multiple R&D initiatives across proteomics, metabolomics, and computational modeling.
As CTO, she drives Fluidome’s technology roadmap, ensuring robust platform architecture, seamless integration across components, and readiness for scale and commercialization.
Bahareh Babamiri, PhD
CSO & Head of Biosensing Technologies
Advancing high-performance biosensing technologies for real-world diagnostics
Dr. Bahareh Babamiri leads biosensor development at Fluidome, driving innovation in high-performance diagnostic platforms. Her work focuses on translating advanced sensing technologies into scalable solutions for real-world healthcare applications.
With expertise at the intersection of nanotechnology, molecular recognition, and microfluidics, she is instrumental in advancing Fluidome’s core sensing capabilities and ensuring strong analytical performance across applications.
Scientific Leadership
Mohammadreza Farrokhnia, PhD
Head of Microfluidics & Platform Innovation
Engineering scalable microfluidic platforms from concept to manufacturable systems
Dr. Mohammadreza Farrokhnia leads the development of Fluidome’s core microfluidic and integrated biosystem platforms. He is responsible for transforming complex biological workflows into scalable, manufacturable technologies that enable seamless sample-to-answer solutions.
His expertise includes microfluidics, electrode design and fabrication, system integration, multiplexing, and device engineering. He plays a key role in bridging innovation and productization, ensuring Fluidome’s platforms are robust, scalable, and deployment-ready.
Mohammad Mehdi Banoei, PhD
Scientist, Metabolomics AND Data Intelligence
Turning complex biological data into actionable diagnostic intelligence
Dr. Mohammad Mehdi Banoei specializes in metabolomics, biomarker discovery, and advanced data analytics, supporting Fluidome’s pipeline from data generation to actionable insights.
His expertise includes mass spectrometry and NMR-based metabolomics, multivariate analysis, and machine learning–driven predictive modeling. He integrates complex biological data with clinical parameters to identify robust diagnostic and prognostic biomarkers.
His work ensures that Fluidome’s technologies are grounded in high-quality data, biological relevance, and real-world clinical utility.
Bahareh Zarin, PhD
Scientist, Organ-on-Chip & Translational Models
Driving end-to-end translation of biomarker discovery into scalable diagnostic products
Dr. Bahareh Zarin develops advanced organ-on-chip and tissue-engineered platforms at Fluidome, enabling predictive in vitro models for disease research and therapeutic testing.
Her expertise combines bioengineering with molecular and cellular biology to model complex biological systems, including cell–microbe interactions and treatment responses.
She plays a key role in strengthening Fluidome’s platform by enabling more predictive validation environments and accelerating translation from discovery to application.
Pezhman Jalali, PhD
Scientist, Microfluidics AND Device Innovation
Translating capillary microfluidics into scalable diagnostic and wearable solutions
Dr. Pezhman Jalali focuses on the development of capillary-driven microfluidic technologies for diagnostic and wearable applications. He specializes in translating microfluidic concepts into scalable, manufacturable solutions.
He is the inventor of the Cap-Drop platform for droplet-based assays and has contributed to the development of wearable systems for real-time biomarker monitoring. His expertise includes passive microfluidics, rapid prototyping, and fabrication using CO₂ laser micromachining, 3D printing, and polymer-based systems.
Dr. Jalali plays a critical role in advancing Fluidome’s device innovation and manufacturing readiness.
Dr. Mehdi Mohammadi is the Co-Founder and CEO of Fluidome, where he leads corporate strategy, product development, and commercialization of next-generation diagnostic and analytical platforms. He oversees the full innovation pipeline—from biomarker discovery to scalable, market-ready biosensor technologies.
With over 20 years of experience across engineering, biotechnology, and translational medicine, he has led 30+ multidisciplinary R&D programs and contributed to the development and commercialization of multiple technologies. His expertise spans metabolomics, microfluidics, and electrochemical biosensing.
Dr. Mohammadi brings a strong combination of technical depth and business leadership, driving product–market fit, strategic partnerships, and growth in the life sciences and diagnostics sectors.
Advisory Board
Guided by experts in metabolomics and systems biology.
Stephanie Bishop, PhD
Assistant Professor, Western University
Metabolomics, Host-Microbiome and Microbial Crosstalk
Dr. Stephanie Bishop is an Assistant Professor of Biochemistry at Western University and an expert in mass spectrometry–based metabolomics and microbial biochemistry. Her research focuses on developing advanced LC–MS analytical platforms to investigate host–microbe interactions, microbial community metabolism, and mechanisms of antimicrobial resistance. By integrating innovative sample preparation technologies, metabolomics workflows, and systems biology approaches, Dr. Bishop’s work enables the discovery and quantification of metabolites in complex biological systems, with applications in infectious disease research and therapeutic development. Her expertise in metabolomics, microbial ecosystems, and analytical method development brings valuable scientific and translational insight to Fluidome’s mission of advancing metabolomics technologies.